Skip to main content

Table 1 Patient and quality control characteristics by sample type

From: Quantitative criteria for improving performance of buccal DNA for high-throughput genetic analysis

N

All

Buccal

Blood

 

850

708 (83%)

142 (17%)

Patient

   

Age (years ± SD)

66.7 ± 14.8

67.2 ± 14.8

64.6 ± 14.9

Sex (% male)

417 (49.1%)

348 (49.2%)

69 (48.6%)

Stroke status (% cases)

433 (50.9%)

353 (49.9%)

80 (56.3%)

Cigarette smoker (% current)

163 (19.2%)

136 (19.2%)

27 (19.0%)

Pre-genotyping QC

   

QC Failure (%)a

90 (10.6%)

80 (11.3%)

10 (7.0%)

cQC <0.4

75 (8.8%)

69 (9.7%)

6 (4.2%)

 DM call rate <83%

65 (7.6%)

60 (8.5%)

5 (3.5%)

 Gender mismatch

24 (2.8%)

19 (2.7%)

5 (3.5%)

 cQC rate

2.08 ± 0.94

2.00 ± 0.94

2.53 ± 0.82***

 Among passed samples

2.33 ± 0.65

2.24 ± 0.65

2.69 ± 0.55***

 Among failed samples

0.05 ± 0.43

0.01 ± 0.37

0.36 ± 0.71

DM call rate

93.1 ± 7.8%

92.7 ± 8.3%

95.1 ± 4.0% ***

 Among passed samples

95.3 ± 2.8%

95.1 ± 2.9%

96.0 ± 1.9% ***

 Among failed samples

74.7 ± 11.7%

73.5 ± 11.7%

83.9 ± 6.9% **

  1. N (%) or mean ± SD presented.
  2. a Failure subsets do not add to total failed samples, as samples frequently fail for more than one reason.
  3. ** p < 0.01 blood vs. buccal samples; ***p < 0.0001 blood vs. buccal samples.